BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1279607)

  • 21. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
    Sager PT; Behboodikhah M
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
    J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
    Naitoh N; Washizuka T; Takahashi K; Aizawa Y
    Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
    Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
    Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertonic saline does not reverse the sodium channel blocking actions of lidocaine: evidence from electrophysiologic and defibrillation studies.
    Ujhelyi MR; Schur M; Frede T; Bottorff MB; Gabel M; Markel ML
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):61-8. PubMed ID: 9007672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The class III antiarrhythmic effect of sotalol exerts a reverse use-dependent positive inotropic effect in the intact canine heart.
    Peralta AO; John RM; Gaasch WH; Taggart PI; Martin DT; Venditti FJ
    J Am Coll Cardiol; 2000 Oct; 36(4):1404-10. PubMed ID: 11028502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart.
    Raatikainen MJ; Napolitano CA; Druzgala P; Dennis DM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1454-63. PubMed ID: 8667210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
    Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ
    Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sotalol and acute ventricular dilatation on action potential duration and dispersion of repolarization after defibrillation shocks.
    Kirchhof P; Milberg P; Eckardt L; Breithardt G; Haverkamp W
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):640-8. PubMed ID: 12658067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
    Newman D; Dorian P; Feder-Elituv R
    Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine.
    Opincariu M; Varró A; Iost N; Virág L; Hála O; Szolnoki J; Szécsi J; Bogáts G; Szenohradszky P; Mátyus P; Papp JG
    Curr Med Chem; 2002 Jan; 9(1):41-6. PubMed ID: 11860346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. d,l-Sotalol at therapeutic concentrations facilitates the occurrence of long-lasting non-stationary reentry during ventricular fibrillation in isolated rabbit hearts.
    Hsieh YC; Horng TL; Lin SF; Lin TC; Ting CT; Wu TJ
    Circ J; 2009 Jan; 73(1):39-47. PubMed ID: 19008631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T; Campa MA; Nadeau R; Dubuc M; Kaltenbrunner W; Shenasa M
    Am Heart J; 1992 Jan; 123(1):82-9. PubMed ID: 1729853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steady-state and dynamic behavior of ventricular repolarization and refractoriness in the dog: the effect of multiple cycle length changes and d-sotalol administration.
    Leerssen HM; Vos MA; den Dulk K; van der Zande J; Muijtjens AM; Begemann MJ; Wellens HJ
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1766-77. PubMed ID: 9744441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
    Kirchhof P; Degen H; Franz MR; Eckardt L; Fabritz L; Milberg P; Läer S; Neumann J; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2003 Apr; 305(1):257-63. PubMed ID: 12649377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
    Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
    Finance O; Manning A; Chatelain P
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of ventricular fibrillation based on monophasic action potential morphology in the human heart.
    Swartz JF; Jones JL; Fletcher RD
    Circulation; 1993 Jun; 87(6):1907-14. PubMed ID: 8504503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.